{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:29:00Z","timestamp":1790814540002,"version":"4.1.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1038\/sj.bjc.6601303","type":"journal-article","created":{"date-parts":[[2008,7,24]],"date-time":"2008-07-24T12:13:40Z","timestamp":1216901620000},"page":"304-305","source":"Crossref","is-referenced-by-count":117,"title":["Fatal outcome of a hypersensitivity reaction to paclitaxel: a critical review of premedication regimens"],"prefix":"10.1038","volume":"90","author":[{"given":"J S","family":"Kloover","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A den","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J P van","family":"Meerbeeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2004,1,20]]},"reference":[{"key":"BF6601303_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1023\/A:1008207025430","volume":"8","author":"MA Bookman","year":"1997","unstructured":"Bookman MA, Kloth DD, Kover PE, Smolinski S, Ozols RF (1997) Short-course intravenous prophylaxis for paclitaxel-related hypersensitivity reactions. Ann Oncol 8: 611\u2013614","journal-title":"Ann Oncol"},{"key":"BF6601303_CR2","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1136\/bmj.280.6228.1353","volume":"280","author":"D Dye","year":"1980","unstructured":"Dye D, Watkins J (1980) Suspected anaphylactic reaction to Cremophor EL. BMJ 280: 1353","journal-title":"BMJ"},{"key":"BF6601303_CR3","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1016\/S0959-8049(01)00171-X","volume":"37","author":"H Gelderblom","year":"2001","unstructured":"Gelderblom H, Verweij J, Nooter K, Sparreboom A (2001) Cremophor EL: the drawbacks and advantages of vehicle delection for drug formulation. Eur J Cancer 37: 1590\u20131598","journal-title":"Eur J Cancer"},{"key":"BF6601303_CR4","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1345\/aph.10287","volume":"35","author":"PE Kintzel","year":"2001","unstructured":"Kintzel PE (2001) Prophylaxis for paclitaxel hypersensitivity reactions. Ann Pharmacother 35: 1114\u20131117","journal-title":"Ann Pharmacother"},{"key":"BF6601303_CR5","first-page":"283","volume":"24","author":"H Koppler","year":"2001","unstructured":"Koppler H, Heymanns J, Weide R (2001) Dose reduction of steroid premedication for paclitaxel: no increase of hypersensitivity reactions. Onkologie 24: 283\u2013285","journal-title":"Onkologie"},{"key":"BF6601303_CR6","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1200\/JCO.2002.12.112","volume":"20","author":"P Kosmidis","year":"2002","unstructured":"Kosmidis P, Mylonakis N, Nicolaides C, Kalophonos Ch, Samantas E, Boukovinas J, Fountzilas G, Skarlos D, Economopoulos Th, Tsavdaridis D, Papakostas P, Bacoyiannis Ch, Dimopoulos M (2002) Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: a phase III randomized trial. J Clin Oncol 20: 3578\u20133585","journal-title":"J Clin Oncol"},{"key":"BF6601303_CR7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1006\/gyno.2001.6546","volume":"84","author":"JS Kwon","year":"2002","unstructured":"Kwon JS, Elit L, Finn M, Hirte H, Mazurka J, Moens F, Trim K (2002) A comparison of two prophylactic regimens for hypersensitivity reactions to paclitaxel. Gynecol Oncol 84: 420\u2013425","journal-title":"Gynecol Oncol"},{"key":"BF6601303_CR8","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1007\/s004320050297","volume":"125","author":"M Markman","year":"1999","unstructured":"Markman M, Kennedy A, Webster K, Peterson G, Kulp B, Belinson J (1999) An effective and more convenient drug regimen for prophylaxis against paclitaxel-associated hypersensitivity reactions. J Cancer Res Clin Oncol 125: 427\u2013429","journal-title":"J Cancer Res Clin Oncol"},{"key":"BF6601303_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1006\/gyno.1998.4993","volume":"69","author":"JP Micha","year":"1998","unstructured":"Micha JP, Rettenmaier MA, Dillman R, Fraser P, Birk C, Brown JV (1998) Single-dose dexamethasone paclitaxel premedication. Gynecol Oncol 69: 122\u2013124","journal-title":"Gynecol Oncol"},{"key":"BF6601303_CR10","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0006-3223(96)00094-7","volume":"41","author":"BT O'Sullivan","year":"1997","unstructured":"O'Sullivan BT, Cutler DJ, Hunt GE, Walters C, Johnson GF, Catherson ID (1997) Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects. Biol Psychiatry 41: 574\u2013584","journal-title":"Biol Psychiatry"},{"key":"BF6601303_CR11","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1200\/JCO.1996.14.7.2189","volume":"14","author":"B Parikh","year":"1996","unstructured":"Parikh B, Khanolkar S, Advani SH, Dhabhar B, Chandra M (1996) Safety profile of single-dose dexamethasone premedication for paclitaxel. J Clin Oncol 14: 2189\u20132190","journal-title":"J Clin Oncol"},{"key":"BF6601303_CR12","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jcp.53.4.273","volume":"53","author":"RSH Pumphrey","year":"2000","unstructured":"Pumphrey RSH, Roberts ISO (2000) Postmortem findings after fatal anaphylactic reactions. J Clin Pathol 53: 273\u2013276","journal-title":"J Clin Pathol"},{"key":"BF6601303_CR13","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","volume":"332","author":"EK Rowinsky","year":"1995","unstructured":"Rowinsky EK, Donehower RC (1995) Paclitaxel (taxol). N Engl J Med 332: 1004\u20131014","journal-title":"N Engl J Med"},{"key":"BF6601303_CR14","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1567-5769(01)00006-6","volume":"1","author":"J Szebeni","year":"2001","unstructured":"Szebeni J, Alving CR, Savay S (2001) Formation of complement-activating particles in aqueous solutions of taxol: possible role in hypersensitivity reactions. Int Immunopharmacol 1: 721\u2013735","journal-title":"Int Immunopharmacol"},{"key":"BF6601303_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/BF00144273","volume":"6","author":"RB Weiss","year":"1987","unstructured":"Weiss RB, Baker Jr JR (1987) Hypersensitivity reactions from antineoplastic agents. Cancer Metast Rev 6: 413\u2013432","journal-title":"Cancer Metast Rev"},{"key":"BF6601303_CR16","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1200\/JCO.1990.8.7.1263","volume":"8","author":"RB Weiss","year":"1990","unstructured":"Weiss RB, Donehower RC, Wiernik PH, Ohnuma T, Gralla RJ, Trump DL, Baker JR, Van Echo DA, Von Hoff DD, Leyland-Jones B (1990) Hypersensitivity reactions from taxol. J Clin Oncol 8: 1263\u20131268","journal-title":"J Clin Oncol"},{"key":"BF6601303_CR17","doi-asserted-by":"publisher","first-page":"767","DOI":"10.2165\/00002018-200124100-00005","volume":"24","author":"KM Zanotti","year":"2001","unstructured":"Zanotti KM, Markman M (2001) Prevention and management of antineoplastic-induced hypersensitivity reactions. Drug Saf 24: 767\u2013779","journal-title":"Drug Saf"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601303","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601303.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:53:04Z","timestamp":1684414384000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF6601303"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601303","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}